FDA-cleared profile

uAI EasyTriage-Rib

Shanghai United Imaging Intelligence Co., Ltd. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.

Clinical role
Triage and notification software whose AI algorithm analyzes CT chest images and flags studies with suspected multiple (3 or more) acute rib fractures on the radiologist's Studylist Application for prioritization, in parallel to standard of care.
Images and patients
CT/CTA · Chest/Lung
Key limitation
Keep in mind: Not diagnostic, does not alter original images, and chronic fractures, pseudoarthrosis, or malunion may be difficult to distinguish from acute fractures.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Chest/Lung Input: Chest CT images; performance data used slices greater than 1 mm from GE and Siemens scanners.
  • Who uses it?Intended users: Hospital networks and trained radiologists.
  • What does the software produce?Output: Passive Studylist or workstation notifications with compressed informational previews.
  • What is its most important limitation?Key limitation: Not diagnostic, does not alter original images, and chronic fractures, pseudoarthrosis, or malunion may be difficult to distinguish from acute fractures.

Clinical takeaway. Clinical role: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.

Evidence takeaway. Evidence from the reviewed source record: Blinded multicenter retrospective study of 200 cases reported sensitivity 92.7%, specificity 84.7%, AUC 0.939, and notification time 69.56 seconds for 76 true positives.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
  • Exact FDA submission
  • Checked 2026-09-15

Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.

Workflow role
Triage and notification software whose AI algorithm analyzes CT chest images and flags studies with suspected multiple (3 or more) acute rib fractures on the radiologist's Studylist Application for prioritization, in parallel to standard of care.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "uAI EasyTriage-Rib is a radiological computer-assisted triage and notification software device for analysis of CT chest images." … "uses an artificial intelligence algorithm to analyze images and highlight studies with suspected multiple (3 or more) acute rib fractures in a standalone application for study list prioritization or triage in parallel to ongoing standard of care.". Read from the exact FDA decision document on 2026-11-14.

Required input
Chest CT images; performance data used slices greater than 1 mm from GE and Siemens scanners.
  • Exact FDA submission
  • Checked 2026-09-15

FDA packet input scope.

Output and clinician action
Passive Studylist or workstation notifications with compressed informational previews.
  • Exact FDA submission
  • Checked 2026-09-15

FDA packet output scope.

Care setting
Trauma CT chest studies; the device is intended to assist hospital networks and trained radiologists in workflow triage, and the FDA document does not further specify a facility type.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "for analysis of CT chest images. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and prioritizing trauma studies with suspected positive findings of multiple (3 or more) acute rib fractures.". Read from the exact FDA decision document on 2026-11-14.

Intended users
Hospital networks and trained radiologists.
  • Exact FDA submission
  • Checked 2026-09-15

FDA packet intended-user statement.

Limitations
Not diagnostic, does not alter original images, and chronic fractures, pseudoarthrosis, or malunion may be difficult to distinguish from acute fractures.
  • Exact FDA submission
  • Checked 2026-09-15

Exact FDA limitation boundary.

Evidence summary
Blinded multicenter retrospective study of 200 cases reported sensitivity 92.7%, specificity 84.7%, AUC 0.939, and notification time 69.56 seconds for 76 true positives.
  • Exact FDA submission
  • Checked 2026-09-15

Submission-reported performance result.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Blinded multicenter retrospective study of 200 cases reported sensitivity 92.7%, specificity 84.7%, AUC 0.939, and notification time 69.56 seconds for 76 true positives.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-15

Submission-reported performance result.

Reported sensitivity
92.7% (95% CI: 84.8%, 97.3%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
84.7% (95% CI: 77.0%, 90.7%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

uAI EasyTriage-Rib regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationPopulation described in the exact-submission ACR model card
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K193271
  • Samplen=200
  • IndependenceIndependence not established

K193271

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K193271. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Chest CT images; performance data used slices greater than 1 mm from GE and Siemens scanners.

    Scope: Exact FDA submission. FDA packet input scope.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-15 · FDA K193271: uAI EasyTriage-Rib

  2. Routing

    Source context, not route validation: The exact FDA package describes DICOM data downloaded from the PACS for analysis, with notifications that include compressed preview images shown in the Studylist Application. Interface versions and local compatibility require confirmation.

    Scope: Exact FDA submission. Packet wording: "The uAI EasyTriage-Rib time-to-notification is defined from the beginning of downloading the DICOM data from the PACS to the time of notification shown in the Studylist." … "Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-11-14 · FDA K193271: uAI EasyTriage-Rib

  3. AI processing

    Source context, not route validation: The exact FDA package describes two modules, a uAI EasyTriage-Rib Server and a Studylist Application that shows notifications on the radiologist's workstations. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "The device consists of the following two modules: (1) uAI EasyTriage-Rib Server; and (2) uAI EasyTriage-Rib Studylist Application that provides the user interface in which notifications from the application are received." … "The subject device flags cases with the suspected positive findings on the Studylist Application on the workstations of the radiologist.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K193271: uAI EasyTriage-Rib

  4. Returned objects

    Source context, not route validation: Passive Studylist or workstation notifications with compressed informational previews.

    Scope: Exact FDA submission. FDA packet output scope.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-15 · FDA K193271: uAI EasyTriage-Rib

  5. Viewer/worklist/report

    Unresolved route: Passive Studylist or workstation notifications with compressed informational previews.

    Scope: Exact FDA submission. FDA packet output scope.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-15 · FDA K193271: uAI EasyTriage-Rib

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes two modules, a uAI EasyTriage-Rib Server and a Studylist Application that shows notifications on the radiologist's workstations. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The device consists of the following two modules: (1) uAI EasyTriage-Rib Server; and (2) uAI EasyTriage-Rib Studylist Application that provides the user interface in which notifications from the application are received." … "The subject device flags cases with the suspected positive findings on the Studylist Application on the workstations of the radiologist.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact FDA package describes DICOM data downloaded from the PACS for analysis, with notifications that include compressed preview images shown in the Studylist Application. Interface versions and local compatibility require confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The uAI EasyTriage-Rib time-to-notification is defined from the beginning of downloading the DICOM data from the PACS to the time of notification shown in the Studylist." … "Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Training
The 510(k) summary states uAI EasyTriage-Rib is intended to assist hospital networks and trained radiologists in workflow triage by flagging and prioritizing studies with suspected findings in chest CT images.
  • Exact FDA submission
  • Checked 2026-10-27

User qualification wording only; the summary specifies no training program or training offering for this device.

Result destination

workstation is explicitly referenced as a result destination.

exact submission · checked 2026-09-01

Confirm supported products, versions, routing behavior, and display requirements during local evaluation.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for uAI EasyTriage-Rib; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K193271
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-15

FDA chest CT scope normalized to controlled CT bucket.

Anatomy
Chest/Lung
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-15

FDA chest and rib-fracture scope.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2021-01-15
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
29Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K193271 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-09 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K193271: uAI EasyTriage-Rib

    U.S. Food and Drug Administration - Published 2021-01-15 - Accessed 2026-09-19

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary, deployment, integration

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. uAI EasyTriage-Rib model card (K193271)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K193271

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

Research history

  1. K193271 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K230020

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: Chest CT (with or without contrast) triage and notification for suspected three or more acute rib fractures in adults or transitional adolescents age 18 or older; notifications are non-diagnostic and clinicians review the original study.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2023-02-01
FDA-cleared K222692

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: Chest and abdominal CT triage and notification for suspected vertebral compression fractures in the standard-of-care bone-health workflow; notifications are non-diagnostic and clinicians review the original study.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2022-12-05
FDA-cleared K242919

V5med Lung AI

V5med Inc.

Authorized purpose: V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2025-03-27
FDA-cleared K222277

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of CTPA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspected positive findings of Pulmonary Embolism (PE) pathologies. Briefcase uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a Stand-Alone Performance desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device. The results of BriefCase are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2022-08-26

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history